Research Paper Volume 13, Issue 9 pp 12493—12513

A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer

Creation of a predictive nomogram in The Cancer Genome Atlas (TCGA) dataset. (A) A prognostic nomogram predicting 1-, 2-, and 3-year overall survival of patients with pancreatic cancer. (B) Time-dependent receiver operating characteristic (ROC) curves for 1-, 2-, and 3-year overall survival predictions of the nomogram. (C) Calibration plot for the validation of the prognostic nomogram. (D) The nomogram predicting OS were compared against AJCC stage by DCA. (E) A predictive nomogram predicting drug reaction in pancreatic cancer. (F) ROC curve of the nomogram for the prediction of chemotherapy resistance. (G) Calibration plot for the validation of the chemotherapy resistance predictive nomogram.

Figure 7. Creation of a predictive nomogram in The Cancer Genome Atlas (TCGA) dataset. (A) A prognostic nomogram predicting 1-, 2-, and 3-year overall survival of patients with pancreatic cancer. (B) Time-dependent receiver operating characteristic (ROC) curves for 1-, 2-, and 3-year overall survival predictions of the nomogram. (C) Calibration plot for the validation of the prognostic nomogram. (D) The nomogram predicting OS were compared against AJCC stage by DCA. (E) A predictive nomogram predicting drug reaction in pancreatic cancer. (F) ROC curve of the nomogram for the prediction of chemotherapy resistance. (G) Calibration plot for the validation of the chemotherapy resistance predictive nomogram.